can you get pregnant on retatrutide Helps People Lose Up To 30% Of Body Weight In Clinical Trial Trying to Conceive? Here’s what

Post-marketing surveillance data from regulatory authorities, including the MHRA's Yellow Card scheme, have similarly not identified a clear signal suggesting increased thyroid cancer risk in the general population using these medications

Stable for years under reasonable conditions

Change history 17 June 2026 In the version of this article initially published online, there were duplication errors in the Extended Data Fig

The backbone is primarily built on a GIP receptor agonist scaffold, which was then systematically modified to introduce cross-reactivity at the GLP-1 and glucagon receptors

SeekPeptides has tracked both of these compounds through every phase of development, and the data tells a more nuanced story than most sources suggest

We anticipate around seven actual launches in the US by 2030 after risk-adjustment